Pharma firms stash profits in Europe's tax havens as patients struggle with drug prices
When doctors removed Miriam Staunton's tumour from her armpit six years ago, they told the 51-year-old Irish woman that she had a 70 per cent chance of relapse. Yet, in the months following the operation, she was only offered local radiation and regular check-ups, but no drug treatment. "I remember when I met the oncologist and he said that he wasn't in a position to offer me anything systemic at that point," Staunton recalls. "I didn't really understand exactly what he meant by it at that tim...
Read more at investigate-europe.eu